Adulterated Presence of Foreign Tablets: Customer complaint that some Endocet 10 mg/325 mg tablets were found mixed in a bottle with Endocet 10 mg/650 mg tablets.
Endo Pharmaceuticals is recalling specific bottles of Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg because some were found mixed with Endocet 10 mg/325 mg tablets. This recall affects 11,764 bottles distributed nationwide and in Puerto Rico. The record does not specify a remedy or action for consumers. Read more at govinfonow.com/recall/48895-endo-pharmaceuticals-inc-recalls-endocet-oxycodone-and-acetaminophen-tablets-usp.
“Endocet Recall: Foreign Tablets in Endocet Bottles.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48895-endo-pharmaceuticals-inc-recalls-endocet-oxycodone-and-acetaminophen-tablets-usp. Based on FDA recall #D-1381-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1381-2012%22&limit=1).
The FDA announced on May 7, 2012, that Endo Pharmaceuticals, Inc. voluntarily recalled Endocet (oxycodone and acetaminophen) tablets due to the adulterated presence of foreign tablets. The agency stated that some Endocet 10 mg/325 mg tablets were found mixed in bottles with the intended 10 mg/650 mg dosage.
How to tell if you have it
Brand: Endo Pharmaceuticals
Product: Endocet 10 mg/650 mg Tablets
NDC: 60951-797-70
Lot #: 402794NV
Expiration Date: 12/13
Quantity: 11,764 bottles
The hazard
The hazard involves the adulterated presence of foreign tablets, specifically Endocet 10 mg/325 mg tablets mixed in with bottles containing Endocet 10 mg/650 mg tablets. This issue was identified following a customer complaint.
Context
GovInfoNow's records show Endo Pharmaceuticals, Inc. has had four other recalls on record since February 22, 2017. Other recent recalls of similar products include Endo Clonazepam Tablets Recalled Due to Labeling Error (July 10, 2024), Endo Recalls Calcitonin Salmon Nasal Spray Due to Impurity Issues (March 2, 2023), and Endo Robaxin 750mg Tablets: Incorrect Dosage Label Recall (September 17, 2018). Other recent recalls of similar products include Annora Pharma Pitavastatin Tablets 2mg Recall (February 3, 2026), Taro Recalls Children's Ibuprofen Due to Foreign Substance (March 2, 2026), and Endo USA Buprenorphine Injection Recall (March 13, 2026).
How to tell if you have this one
Check if you have Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, in a 100-count bottle. Look for NDC 60951-797-70, Lot #402794NV, and an expiration date of 12/13.
Brand
Endo Pharmaceuticals
Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1381-2012 (May 7, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1381-2012 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.